Cell Therapy Analytical Development Summit Europe

Memo

Join Your Analytical Community in London in 2022! The inaugural Cell Therapy Analytical Development Summit Europe is the leading industry-defining forum in Europe made exclusively for analytical, CMC, QC, process development and regulatory experts. Next generation cell therapies are emerging as game changing treatments for cancer and beyond, but given their increasing complexities, developing robust, reliable, and in-depth analytical assays is critical to prove their safety and quality to the regulatory authorities. This year we have unrivalled content showcasing: • Efforts to harmonise reference standards for state-of-the-art analytical development• Regulatory experience case studies to hit guidelines and avoid pushback• Strategies to develop a successful potency assay to determine product activity• Process transfers demonstrating analytical robustness and product comparability• New technology to expand and improve your analytical toolbox• Development and validation of analytical methods to fulfil GMP guidelines• Best methods to approach final product characterisation by starting with the end in mind• Automated technologies for improved accuracy, repeatability and speed … To provide your team with the lessons learned to achieve success in analytical submissions from IMPD/IND through to the clinic and beyond. Data and learnings will be shared from key European biopharma stakeholders including Cellectis, Gadeta, GSK, and Sanofi and more to support your efforts in developing efficacious, potent and safe cell therapies. Unite with these companies and more this August to fast-track your pipeline into the clinic and beyond.https://cell-therapy-analytics.com/ 23-25 August, 20228.30am-5pm BST | London, UK Contact:This email address is being protected from spambots. You need JavaScript enabled to view it. Brochure https://go.evvnt.com/1150433-0?pid=5569Tickets https://go.evvnt.com/1150433-2?pid=5569 Prices:Drug Developers - Standard Pricing (Earlybird rates & workshops available) GBP 2499.00Academic - Standard Pricing (Earlybird rates & workshops available) GBP 1999.00Service Providers - Standard Pricing (Earlybird rates & workshops available) GBP 2899.00 Speakers: Assegid Oumie, Principal Scientist, Analytical Development Lead, Enara Bio, Benoit Champluvier, Executive Director, Process & Analytical Development, Cellectis, Eesha Vyas, Regulatory Affairs Manager, Oncology, GlaxoSmithKline, Sharon Longhurst, Vice President of Development, Gadeta, Berkan Vural, Cell Analytical Scientist, GlaxoSmithKline, Christopher Bravery, Regulatory Scientist, Independent Consultant, Jeetendra Kumar, Specialist R&D, Immuneel Therapeutics, Sofia Håkansson Buch, Vice President, Cell Therapy CMC, Novo Nordisk, Arindam Mitra, Associate Director, CMC, Leucid Bio, Chaya Mazouz, Vice President, Quality (IL) & Global Regulatory Affairs, Orgenesis, Driss Chader, Analytical Development Engineer, Cellectis, Farzin Farzaneh, Chair of Molecular Medicine, King's College London, Adi Zohar, Quality Control Manager, Pluristem Therapeutics, Ruti Goldberg, Compliance & Methods Validations Manager, Pluristem Therapeutics, Yvet Noordman, Head of Analytical Development, Bioanalytics Genomic Medicine, Sanofi, Hélène Negre, EPFIA Project Leader, T2Evolve IMI Consortium, Servier, Mohamad Toutounji, ADQC Scientist, Cell Therapy, Sanofi, Terri Gaskell, Chief Technology Officer, Rinri Therapeutics, Emilio Cosimo, Product Development Manager, TC BioPharm, Katherine Cornish, Senior Stem Cell Biologist, Head of Cell Therapy, UK Stem Cell Bank, NIBSC, Therese Choquette, Head of Analytical Science, Tigen Pharma Dates and Time: Starts: Tue, Aug 23, 2022 ( 8:30 AM) and Ends: Thu, Aug 25, 2022 ( 7:00 PM) Venue details: Hilton London Paddington, 146 Praed St, London, W2 1EE, United Kingdom